West Enclave Merger Corp

West Enclave Merger Corp(WENC)の株式分析

$10.010

+0.010 (+0.10%)終値時点

Loading chart…
High
10.010
Open
10.000
VWAP
10.01
Vol
18.28K
Mkt Cap
Low
10.000
Amount
182.89K
EV/EBITDA, TTM
0.00

West Enclave Merger Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The Company has conducted no operations and has generated no revenues.

AI analysis of West Enclave Merger Corp (WENC)

hold

West Enclave Merger Corp. (WENC) is not a strong buy at this moment. The current price is $9.98, and the RSI is at 48.34, indicating a neutral momentum. The company has a high debt-to-equity ratio of 20.32%, which poses a risk, especially given its negative net income of $40,398 in Q1 2026. While the stock has shown a slight increase of 1.27% year-to-date, the lack of positive financial performance and high valuation metrics suggest caution.

バリュエーション指標

The current forward P/E ratio for West Enclave Merger Corp (WENC) is 0.00, compared to its 5-year average forward P/E of .

Forward P/E

5Y Average P/E
Current P/E
0.00

Forward EV/EBITDA

5Y Average EV/EBITDA
Current EV/EBITDA
0.00

Forward P/S

5Y Average P/S
Current P/S
0.00

WENC FAQ — answered by Alphio AI

West Enclave Merger Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The Company has conducted no operations and has generated no revenues. It operates in the Financials sector.

West Enclave Merger Corp. (WENC) is not a strong buy at this moment. The current price is $9.98, and the RSI is at 48.34, indicating a neutral momentum. The company has a high debt-to-equity ratio of 20.32%, which poses a risk, especially given its negative net income of $40,398 in Q1 2026. While the stock has shown a slight increase of 1.27% year-to-date, the lack of positive financial performance and high valuation metrics suggest caution.

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

無料で始める